BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/3/2026 9:37:22 AM | Browse: 0 | Download: 0
Publication Name World Journal of Stem Cells
Manuscript ID 120831
DOI 10.4252/wjsc.120831
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Mesenchymal stem cells therapy ameliorates esophageal dysmotility in gastroesophageal reflux disease by modulating smooth muscle contractility, alleviating senescence by targeting the DNMT3a-HIF1α axis
Manuscript Source Unsolicited Manuscript
All Author List Yi Li, Wen-Ya Zhu, Bo Zhang, Ze-Rui Wang, Zhao-Yang Chen, Qian-Qian Chen and En-Qiang Linghu
Funding Agency and Grant Number
Funding Agency Grant Number
China Postdoctoral Science Foundation 2020TQ0131
Natural Science Foundation of Beijing Municipality 7232151
Corresponding Author En-Qiang Linghu, Department of Gastroenterology, The First Medical Center, General Hospital of the Chinese PLA, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. linghuenqiang@vip.sina.com
Key Words Mesenchymal stem cells; Gastroesophageal reflux disease; Esophageal dysmotility; DNA methyltransferase 3a/hypoxia-inducible factor 1 alpha axis
Core Tip This work shows mesenchymal stem cells (MSCs) restore impaired esophageal contractility and reduce inflammation in gastroesophageal reflux disease by regulating ion channels and smooth muscle proteins. MSCs counteract tumor necrosis factor-α-accelerated cell senescence and dysfunction, with DNA methyltransferase 3a and hypoxia-inducible factor 1 alpha pathways implicated. These results uncover critical mechanisms for MSC-mediated regenerative effects, proposing a promising cell-based therapeutic approach for restoring physiological function in gastroesophageal reflux disease.
Citation Li Y, Zhu WY, Zhang B, Wang ZR, Chen ZY, Chen QQ, Linghu EQ. Mesenchymal stem cells therapy ameliorates esophageal dysmotility in gastroesophageal reflux disease by modulating smooth muscle contractility, alleviating senescence by targeting the DNMT3a-HIF1α axis. World J Stem Cells 2026; In press
Received
2026-03-13 01:49
Peer-Review Started
2026-03-13 01:49
First Decision by Editorial Office Director
2026-03-26 10:15
Return for Revision
2026-03-26 10:15
Revised
2026-04-07 11:05
Publication Fee Transferred
2026-04-13 11:43
Second Decision by Editor
2026-05-25 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-03 09:37
Articles in Press
2026-06-03 09:37
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com